Related Experiment Video
Updated: Feb 27, 2026

08:47
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
10.3K
Is there a connection between postprandial hyperglycemia and IGT related sensory nerve dysfunction?
Summary
Impaired glucose tolerance (IGT) significantly increases the risk of sensory nerve dysfunction, primarily driven by elevated blood glucose levels, not cardiovascular factors. Age and height also contribute to this nerve damage.
Area of Science:
- Neurology
- Endocrinology
- Diabetology
Background:
- Isolated impaired glucose tolerance (IGT) is a prediabetic state.
- Sensory nerve dysfunction is a potential complication of metabolic disorders.
- Understanding risk factors for nerve dysfunction in IGT is crucial for early intervention.
Purpose of the Study:
- To identify risk factors for sensory nerve dysfunction in individuals with isolated impaired glucose tolerance (IGT).
Main Methods:
- Quantitative sensory testing using the Neurometer device was performed on 72 subjects with IGT and 39 controls.
- Neurological and clinical assessments were conducted.
- Statistical analysis identified independent determinants of sensory nerve dysfunction.
Main Results:
- Sensory nerve dysfunction was significantly more prevalent in subjects with IGT (58.3%) compared to controls (10.3%).
- The association between IGT and nerve dysfunction was primarily linked to glycaemic measures, particularly 120-minute postload glucose levels.
- Independent determinants included older age, elevated 120-minute glucose levels, higher height, and borderline cardiovascular autonomic neuropathy.
Conclusions:
- Sensory nerve dysfunction in IGT is predominantly associated with glycaemic dysregulation rather than cardiovascular factors.
- Age, height, and specific glucose measurements are key predictors of nerve dysfunction in this population.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
Oral Hypoglycemic Agents: Glinides
756
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
756
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K

